Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.

Anticancer research - 1 Jan 2000

Stickeler E, Runnebaum I B, Möbus V J, Kieback D G, Kreienberg R

Abstract excerpt

The expression of standard CD44 protein (CD44std) and its splice variants v5, v6 and v7 was investigated in 43 human ovarian carcinoma cell lines by flow cytometry and immunocytochemistry using monoclonal antibodies raised against extracellular epitopes. Twenty six (60%) cell lines expressed CD44...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Cell Line
Share to Exons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to Gene Expression

Share to Genetic Variation

Share to Immunohistochemistry

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 9216637

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-9216637-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.PMID 9216637Read ↗

Expression and modulation of CD44 variant isoforms in humansSemantic proximity Read ↗

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.Semantic proximity Read ↗

Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.Semantic proximity Read ↗

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisSemantic proximity Read ↗

Expression of CD44 splice variants during lymphocyte activation and tumor progression.Semantic proximity Read ↗

[Occurrence of CD44 and its isoforms under orthological and pathological conditions].Semantic proximity Read ↗

Expression of CD44 splice variants in human skin and epidermal tumours.Semantic proximity Read ↗

Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.Semantic proximity Read ↗

New CD44 splice variants associated with human breast cancers.Semantic proximity Read ↗

CD44 splice variants: expression during lymphocyte activation and tumor progression.Semantic proximity Read ↗

Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products.Semantic proximity Read ↗

CD44 Alternative Splice Variants v6 and v10Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.